USPTO serial 79292719
RYSPARIS MYCITE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 10, 2021
- Examiner
- REINHART, MEGHAN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RYSPARIS MYCITE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott S. Havlick
Scott S. Havlick Holland & Hart LLPP.O. Box 8749, TM DocketingAttn: Trademark DocketingDenver, CO 80201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders in the form of ingestible tablets and pills containing silicon sensor chips; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing silicon sensor chips which transmit information about drug ingestion by the patient | ACTIVE | — |
| 010 | Medical apparatus and instruments for monitoring vital signs of patients; medical diagnostic apparatus and instruments for monitoring vital signs of patients; patient monitoring sensors and alarms; sensor apparatus for medical use in monitoring the vital signs of patients; sensor devices and medical apparatus all for medical use, namely, sensor patches attached to a patient's body for use in measuring, collecting, storing and transmitting patient data and medical information in the nature of drug ingestion information, pulse, heart rate, respiratory rate, body temperature, electric pressure in the body, human motion, human position and sleeping condition | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named RYSPARIS MYCITE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 10, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 12, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 6, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 14, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 14, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 10, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 10, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 25, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 25, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 23, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 5, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 5, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 5, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 16, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 15, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 9, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 21, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 21, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 1, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 12, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 8, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 4, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 3, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |